Salusin-β mediates tubular cell apoptosis in acute kidney injury: Involvement of the PKC/ROS signaling pathway.


Journal

Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639

Informations de publication

Date de publication:
02 2020
Historique:
received: 12 11 2019
revised: 18 12 2019
accepted: 18 12 2019
pubmed: 31 12 2019
medline: 17 4 2021
entrez: 30 12 2019
Statut: ppublish

Résumé

Salusin-β is abundantly expressed in many organs and tissues including heart, blood vessels, brain and kidneys. Recent studies have identified salusin-β as a bioactive peptide that contributes to various diseases, such as atherosclerosis, hypertension, diabetes and metabolic syndrome. However, the role of salusin-β in the pathogenesis of acute kidney injury (AKI) is largely unclear. In the present study, we investigated the roles of salusin-β in cisplatin or lipopolysaccharide (LPS)-induced renal injury. Herein, we found that salusin-β expression was upregulated in both renal tubular cells and kidney tissues induced by both cisplatin and LPS. In vitro, silencing of salusin-β diminished, whereas overexpression of salusin-β exaggerated the increased PKC phosphorylation, oxidative stress, histone γH2AX expression, p53 activation and apoptosis in either cisplatin or LPS-challenged renal tubular cells. More importantly, salusin-β overexpression-induced tubular cell apoptosis were abolished by using the PKC inhibitor Go 6976, reactive oxygen species (ROS) scavenger NAC, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor apocynin (Apo) or p53 inhibitor Pifithrin-α. In animals, blockade of salusin-β alleviated PKC phosphorylation, ROS accumulation, DNA damage, and p53 activation as well as renal dysfunction in mice after administration of cisplatin or LPS. Taken together, these results suggest that overexpressed salusin-β is deleterious in AKI by activation of the PKC/ROS signaling pathway, thereby priming renal tubular cells for apoptosis and death.

Identifiants

pubmed: 31884071
pii: S2213-2317(19)31385-0
doi: 10.1016/j.redox.2019.101411
pmc: PMC6939056
pii:
doi:

Substances chimiques

Intercellular Signaling Peptides and Proteins 0
Lipopolysaccharides 0
Reactive Oxygen Species 0
TOR2A protein, human 0
Protein Kinase C EC 2.7.11.13
Cisplatin Q20Q21Q62J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101411

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Références

Arch Toxicol. 2015 Dec;89(12):2197-205
pubmed: 26564230
Med Sci Monit. 2014 Jul 29;20:1326-33
pubmed: 25070707
J Clin Invest. 2014 Nov;124(11):4989-5001
pubmed: 25295536
PLoS One. 2013 Oct 03;8(10):e76714
pubmed: 24098553
Redox Biol. 2018 Apr;14:600-608
pubmed: 29154191
JAMA. 2005 Aug 17;294(7):813-8
pubmed: 16106006
Toxicol Sci. 2014 Sep;141(1):155-65
pubmed: 24973090
Circ Res. 2010 Apr 30;106(8):1363-73
pubmed: 20339118
Drug Dev Res. 2018 Nov;79(7):315-323
pubmed: 30291750
Neurosci Lett. 2005 Sep 9;385(2):110-3
pubmed: 15961227
Diabetes Metab. 2008 Apr;34(2):148-54
pubmed: 18329309
Front Microbiol. 2017 Oct 30;8:2089
pubmed: 29163391
Nat Rev Mol Cell Biol. 2008 Sep;9(9):690-701
pubmed: 18719708
Nephrol Dial Transplant. 2011 Nov;26(11):3474-84
pubmed: 21478303
Cell Death Dis. 2018 Mar 2;9(3):351
pubmed: 29500339
Expert Opin Ther Targets. 2013 Sep;17(9):1003-9
pubmed: 23865521
Biochim Biophys Acta. 2014 Jul;1842(7):1088-96
pubmed: 24726884
Redox Biol. 2019 Jan;20:261-274
pubmed: 30384260
Aging (Albany NY). 2019 Mar 14;11(5):1510-1523
pubmed: 30875333
Lab Invest. 2018 Jan;98(1):63-78
pubmed: 29106395
Antioxid Redox Signal. 2016 Jun 20;24(18):1045-57
pubmed: 26952533
Circulation. 2008 Feb 5;117(5):638-48
pubmed: 18212280
Toxicol Sci. 2001 Oct;63(2):196-207
pubmed: 11568363
Am J Physiol Renal Physiol. 2007 Oct;293(4):F1282-91
pubmed: 17670903
Can J Physiol Pharmacol. 2012 Apr;90(4):463-71
pubmed: 22462492
Redox Biol. 2019 Sep;26:101266
pubmed: 31279986
Mol Cell. 2017 Jun 15;66(6):801-817
pubmed: 28622525
Int J Cardiol. 2019 Apr 1;280:142-151
pubmed: 30581101
Biochem Biophys Res Commun. 2017 Aug 26;490(3):629-635
pubmed: 28630004
Clin Sci (Lond). 2018 Apr 16;132(7):825-838
pubmed: 29581249
Free Radic Biol Med. 2018 Feb 20;116:101-113
pubmed: 29330095
Kidney Int Suppl. 2007 Aug;(106):S49-53
pubmed: 17653211
J Am Soc Nephrol. 2018 Feb;29(2):449-461
pubmed: 29042455
Biochim Biophys Acta. 2015 Sep;1852(9):1709-18
pubmed: 26001930
Pain. 2016 Jul;157(7):1541-50
pubmed: 26963850
Front Pharmacol. 2017 Dec 14;8:872
pubmed: 29311915
Rom J Intern Med. 2010;48(4):307-12
pubmed: 21528758
Biotech Histochem. 2013 May;88(3-4):153-60
pubmed: 23244237
J Clin Invest. 2019 Nov 1;129(11):4797-4816
pubmed: 31589169
Front Cell Neurosci. 2017 Jan 10;10:301
pubmed: 28119569
Biochem Biophys Res Commun. 2017 Sep 16;491(2):515-521
pubmed: 28647373
J Cardiovasc Pharmacol. 2015 Oct;66(4):323-31
pubmed: 26038832
Redox Biol. 2017 Oct;13:320-330
pubmed: 28623824
Pediatr Nephrol. 2019 Jun;34(6):975-991
pubmed: 30105414
Nat Rev Nephrol. 2018 Oct;14(10):607-625
pubmed: 30135570
Kidney Int. 2018 Apr;93(4):855-870
pubmed: 29276099
Redox Biol. 2019 Jun;24:101195
pubmed: 31004990
J Clin Invest. 2011 Nov;121(11):4210-21
pubmed: 22045571
Pediatr Nephrol. 2015 Mar;30(3):523-31
pubmed: 25245503
Int J Mol Sci. 2018 Jul 13;19(7):
pubmed: 30011818
Circ Res. 2018 Jun 22;123(1):43-56
pubmed: 29794022
Cardiovasc Diabetol. 2016 Oct 12;15(1):146
pubmed: 27733157
Sci Rep. 2015 Jul 29;5:11162
pubmed: 26220637
Acta Physiol (Oxf). 2014 Mar;210(3):534-45
pubmed: 24304512
Cold Spring Harb Perspect Biol. 2010 Aug;2(8):a000935
pubmed: 20679336
J Pharmacol Exp Ther. 2002 Jul;302(1):8-17
pubmed: 12065694
Antioxid Redox Signal. 2019 Dec 20;31(18):1352-1370
pubmed: 31578871
Biotech Histochem. 2014 Feb;89(2):98-103
pubmed: 23957705
Redox Biol. 2019 Jan;20:98-106
pubmed: 30296702
Kidney Int. 2012 Dec;82(12):1271-83
pubmed: 22854643
Biomed Pharmacother. 2018 May;101:842-851
pubmed: 29635893
J Thorac Cardiovasc Surg. 2016 Oct;152(4):1177-87
pubmed: 27353339
Kidney Int. 2019 Feb;95(2):388-404
pubmed: 30551896
Biotech Histochem. 2017;92(2):122-133
pubmed: 28296550
Curr Drug Metab. 2016;17(8):827-833
pubmed: 27364831
J Crit Care. 2016 Feb;31(1):82-9
pubmed: 26475099
Kidney Int. 2008 May;73(9):994-1007
pubmed: 18272962
Oxid Med Cell Longev. 2017;2017:6905217
pubmed: 29359008
Curr Mol Med. 2012 May;12(4):413-25
pubmed: 22364128
Sci Rep. 2017 Feb 23;7:43259
pubmed: 28230187
Redox Biol. 2018 May;15:513-521
pubmed: 29413963
Free Radic Biol Med. 2016 Mar;92:90-99
pubmed: 26795599
Redox Biol. 2019 Sep;26:101234
pubmed: 31247506
Nat Med. 2003 Sep;9(9):1166-72
pubmed: 12910263
Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):
pubmed: 24003211
Toxicol Appl Pharmacol. 2016 Dec 15;313:104-108
pubmed: 27984128
Cell Mol Life Sci. 2016 Aug;73(15):2829-50
pubmed: 26791483
Med Sci Monit. 2018 Oct 02;24:7007-7014
pubmed: 30278036
Cell Death Dis. 2017 Mar 23;8(3):e2690
pubmed: 28333148
Cardiovasc Res. 2013 Jun 1;98(3):344-51
pubmed: 23400761
Antioxid Redox Signal. 2016 Jul 20;25(3):119-46
pubmed: 26906267
J Clin Invest. 2019 Nov 1;129(11):4574-4575
pubmed: 31589167
Oxid Med Cell Longev. 2018 Jan 31;2018:6717212
pubmed: 29636853
Diabetes. 2006 Jun;55(6):1642-50
pubmed: 16731826
Kidney Int. 2019 Apr;95(4):741-743
pubmed: 30904062
Circulation. 1997 Jun 3;95(11):2492-9
pubmed: 9184579
Biomed Res Int. 2014;2014:967826
pubmed: 25165721
Kidney Int. 2016 Mar;89(3):555-64
pubmed: 26880452
Intensive Care Med. 2017 Jun;43(6):816-828
pubmed: 28364303
Am J Kidney Dis. 1986 Nov;8(5):368-79
pubmed: 3538860
Mol Cell Biochem. 2000 Feb;205(1-2):1-11
pubmed: 10821417

Auteurs

Qing-Bo Lu (QB)

Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, 210009, PR China.

Qiong Du (Q)

Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, 214122, PR China.

Hui-Ping Wang (HP)

Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, 214122, PR China.

Zi-Han Tang (ZH)

Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, 214122, PR China.

Yuan-Ben Wang (YB)

Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, 214122, PR China.

Hai-Jian Sun (HJ)

Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, 214122, PR China; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore. Electronic address: phcsunh@nus.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH